DOI: 10.4244/EIJV8I9A170

First-in-human experience: percutaneous renal denervation through a false lumen fenestration in aortic dissection type B

Sebastian Ewen*, MD; Felix Mahfoud, MD; Michael Böhm, MD

A 61-year-old man (height 181 cm, weight 110 kg) presented to our clinic with dyspnoea (NYHA Class II) and progressive chest and abdominal pain. Medical history included an aortic dissection type B with perfusion of the left kidney from the false lumen, diagnosed in 2009 (Figure 1A and Figure 1B). The patient was receiving five antihypertensive drugs (bisoprolol 5 mg ½-0-½, hydrochlorothiazide 25 mg 1-0-0, amlodipine 10 mg 1-0-0, urapidil 90 mg 1-0-1, moxonidine 0.3 mg 1-0-1). Office blood pressure (BP) was 160/95 mmHg. Ambulatory 24-hour BP monitoring confirmed true treatment resistance (mean 141/91 mmHg, non-dipping pattern).

Figure 1. A) Magnetic resonance angiography (MRA) of the aortic arch, showing the entry of the dissection distal of the left subclavian artery. B) MRA, showing the descending aorta with the dissection membrane. Angiography of C) the right renal artery, and D) the left renal artery, before renal denervation (after fenestration).

Renal denervation was performed via femoral access. An 8 Fr IMA guiding catheter (Cordis, Johnson & Johnson, Warren, NJ, USA) was placed into the true aortic lumen at the level of the left renal artery. After a fenestration manoeuvre of the intima flap, performed using an IRON MAN PTCA wire (Abbott Vascular, Redwood City, CA, USA), the Symplicity™ radiofrequency catheter (Medtronic Inc., Minneapolis, MN, USA) was introduced and advanced to the distal segment of the renal artery under fluoroscopy (Figure 1C and Figure 1D, Moving image 1 and Moving image 2). Five treatments of the left artery and six of the right artery were successfully applied.

At three and six-month follow-up, ambulatory 24-hour BP was reduced by 13/10 mmHg and 14/9 mmHg (mean daytime 130/83 mmHg; mean night-time 122/79 mmHg), respectively (Online Figure 1). Six months after treatment, BP was controlled to target (office 130/90 mmHg). MRA showed no sign of complications at six-month follow-up.

Conflict of interest statement

The institution has received scientific support from Medtronic/Ardian. M. Böhm and F. Mahfoud have received speaker honoraria and consultancy fees from Medtronic/Ardian and are supported by Deutsche Forschungsgemeinschaft (KFO 196). F. Mahfoud is supported by Deutsche Hochdruckliga. S. Ewen has no conflicts of interest to declare.

Online data supplement

Online Figure 1. Blood pressure reduction after renal denervation in a patient with aortic dissection type B after three and six months (ambulatory 24-hour blood pressure monitoring).

Moving image 1. Angiography of the right renal artery, before renal denervation (after fenestration).

Moving image 2. Angiography of the left renal artery, before renal denervation (after fenestration).

Online Figure 1. Blood pressure reduction after renal denervation in a patient with aortic dissection type B after three and six months (ambulatory 24-hour blood pressure monitoring).

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1.
Moving image 2.
Volume 8 Number 9
Jan 18, 2013
Volume 8 Number 9
View full issue


Key metrics

Trending articles
200.45

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
154.43

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
92.95

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
47.4

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
43.65

Clinical research

10.4244/EIJ-D-23-00590 Dec 4, 2023
Prognostic impact of cardiac damage staging classification in each aortic stenosis subtype undergoing TAVI
Nakase M et al
free
36.5

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
34.75

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved